Oct. 26, 2022
The College's COVID-19 NewsBrief provides timely curated COVID information and helpful resources for use in your practice and with your patients.

FDA authorizes Novavax’s booster

The FDA authorized Novavax’s COVID-19 booster shot. The shot is authorized for those 18 and older who cannot take one of the bivalent messenger RNA COVID boosters or who otherwise would not get a booster shot.

CDC panel: COVID vaccines should appear on recommended schedule of vaccines

A CDC panel of vaccine experts has recommended that COVID vaccines should be included on the schedule of vaccines that doctors offer to adults and children. State and local officials often look at the list to determine which vaccines are required for school attendance. Additionally, the COVID-19 vaccine will be added to the Vaccines for Children program, which provides free vaccines for children without health insurance.

Study: Most common COVID symptoms have changed

A study has found the most common symptoms for those vaccinated and unvaccinated who have COVID are sore throat, runny nose, cough and headache. Loss of taste/smell and shortness of breath were reported less frequently than earlier on in the pandemic. Researchers found symptoms of the dominant Omicron variant seem to be milder than the previously dominant Delta variant.

Visit the College's COVID-19 page

The College’s COVID-19 resource page has information related to COVID that allergists may need. 
Copyright © 2022 American College of Allergy, Asthma and Immunology, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list